San Francisco, CA (Friday, October 26, 2007) — Although estimates have been adjusted downward in light of the most recent data, researchers still predict sharp increases in the U.S. incidence and prevalence of end-stage renal disease (ESRD) in the years ahead, according to a paper being presented at the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco.
"The expected number of patients with ESRD in 2020 is almost 785,000, which is an increase of over 60 percent compared to 2005," comments Dr. David T. Gilbertson of the U.S. Renal Data System (USRDS) and the Minneapolis Medical Research Foundation, Minneapolis, Minn. Using data available through 2005, the study updates previous estimates based on data through 2000.
The development of tissue engineering technologies and stem cell therapies to repair failing organs will some day drastically reduce the cost of medical care. The sooner these treatments come the more we will save. Treatments that are not effective typically cost more than treatments that are effective. Degenerative diseases of old age that slowly kill people over a period of years are expense to treat. Growth of replacement organs or use of stem cell therapies to do repairs will cost less once those treatments become available.
|Share |||Randall Parker, 2007 November 04 09:46 PM Aging Population Problems|